• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Ted Okon Outlines the Purpose of COA's Payer Exchange Summit

Video

The Community Oncology Alliance (COA) created its Payer Exchange Summit to get payers who are thinking about getting involved in oncology payment reform or want to know what to do exposed to successful pilots, explained Ted Okon, MBA, executive director of COA.

The Community Oncology Alliance (COA) created its Payer Exchange Summit to get payers who are thinking about getting involved in oncology payment reform or want to know what to do exposed to successful pilots, explained Ted Okon, MBA, executive director of COA.

Transcript (slightly modified for readability)

What is the objective of the Community Oncology Alliance's Payer Exchange Summit?

So at COA we had this dream over a year ago of getting providers and payers together at a summit. In fact, we called it the Payer Exchange Summit on Oncology Payment Reform. We wanted to get provider and payer teams that were actually working on oncology payment reform to talk about "what are we doing? What's working? What's not working?"

So now that we've done the first summit a year ago, we did the second summit when we devoted half a day at our conference in April, and now that we've just finished the third summit, we're really seeing a great opportunity here to get more payers involved in the dialogue. Not just the really progressive payers that are actually doing things in oncology payment reform, like Aetna, like UnitedHealthcare, but literally to get payers that are thinking about doing something or want to know what they should be doing to literally have them exposed to pilots that are working now with actual payers and providers.

Related Videos
Will Shapiro
Pat Van Burkleo
Robert Groves, MD
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
Pat Van Burkleo
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.